S Bobo Tanner

S Bobo Tanner


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2023 in Bone
Verified
Journal Article
Closed access
KCKatie R. Cruchelow
Katie R. Cruchelow
MPMegan E. Peter
Megan E. Peter
ACAnwesa Chakrabarti
Anwesa Chakrabarti
HGHannah M. Gipson
Hannah M. Gipson
WGW. Taylor Gregory
W. Taylor Gregory
STS Bobo Tanner
S Bobo Tanner

29 September 2023
Verified
Book Chapter
Open access
PDF file
MFMadeleine E. Frech
Madeleine E. Frech
GAGaniat Adeogun
Ganiat Adeogun
ECErin Chew
Erin Chew
TFTracy Frech
Tracy Frech
STS Bobo Tanner
S Bobo Tanner
Bone health in systemic sclerosis (SSc) is an essential management consideration for rheumatologists caring for these patients. Screening for reduction in bone density includes a detailed health history, which includes SSc disease features such as intestinal malabsorption, patulous esophagus, and calcinosis. The established International Society for Clinical Densitometry (ISCD) guidelines provide an official position statement on important topics in skeletal assessment. Bone health laboratory testing are indicated in all SSc patients, especially if a low serum albumin or vitamin deficiencies are detected. Bone health treatment considerations include adequate weight bearing exercise, calcium, and vitamin D in all SSc patients. The key findings of this chapter is that SSc patients are at increased risk for low bone density and comorbidities may affect choice of treatment such as oral bisphosphonates in SSc patients with significant esophageal disease or renal impairment and osteoanabolic therapies in SSc patients with calcinosis are important.